Global Intravenous Iron Drugs Market Report 2018 - Industry Analysis, Size, Share, production and Forecasts to 2025

 Buy Now

   Published Date : Aug-2018   |    Format : PDF   |    Pages : 90
This report studies the global market size of Intravenous Iron Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous Iron Drugs in these regions.
This research report categorizes the global Intravenous Iron Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality.
Treatment with intravenous iron is clearly superior to oral iron and presents several advantages such as faster and higher increase in Hb levels and replenishment of body iron stores. For these reasons, modern formulations of IV iron have emerged as safe and effective alternatives for IDA management.
In 2017, the global Intravenous Iron Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Intravenous Iron Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Intravenous Iron Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Intravenous Iron Drugs include
    Allergan
    AMAG Pharmaceuticals
    Daiichi Sankyo
    Galenica
    Pharmacosmos
    Nippon Shinyaku
    NOXXON Pharma
    Rockwell Medical
    Sanofi
    Wanbang Biopharmaceutical

Market Size Split by Type
    Ferric carboxy maltose
    Sucrose
    Dextran
Market Size Split by Application
    Nephrology
    Gynecology & Obstetrics
    Gastroenterology
    Oncology
    Cardiology
    Others

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Intravenous Iron Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Intravenous Iron Drugs market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Intravenous Iron Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Intravenous Iron Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Intravenous Iron Drugs submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Intravenous Iron Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intravenous Iron Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Intravenous Iron Drugs Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Intravenous Iron Drugs Market Size Growth Rate by Type
        1.4.2 Ferric carboxy maltose
        1.4.3 Sucrose
        1.4.4 Dextran
    1.5 Market by Application
        1.5.1 Global Intravenous Iron Drugs Market Size Growth Rate by Application
        1.5.2 Nephrology
        1.5.3 Gynecology & Obstetrics
        1.5.4 Gastroenterology
        1.5.5 Oncology
        1.5.6 Cardiology
        1.5.7 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Intravenous Iron Drugs Market Size
        2.1.1 Global Intravenous Iron Drugs Revenue 2016-2025
        2.1.2 Global Intravenous Iron Drugs Sales 2016-2025
    2.2 Intravenous Iron Drugs Growth Rate by Regions
        2.2.1 Global Intravenous Iron Drugs Sales by Regions
        2.2.2 Global Intravenous Iron Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Intravenous Iron Drugs Sales by Manufacturers
        3.1.1 Intravenous Iron Drugs Sales by Manufacturers
        3.1.2 Intravenous Iron Drugs Sales Market Share by Manufacturers
        3.1.3 Global Intravenous Iron Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Intravenous Iron Drugs Revenue by Manufacturers
        3.2.1 Intravenous Iron Drugs Revenue by Manufacturers (2016-2018)
        3.2.2 Intravenous Iron Drugs Revenue Share by Manufacturers (2016-2018)
    3.3 Intravenous Iron Drugs Price by Manufacturers
    3.4 Intravenous Iron Drugs Manufacturing Base Distribution, Product Types
        3.4.1 Intravenous Iron Drugs Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Intravenous Iron Drugs Product Category
        3.4.3 Date of International Manufacturers Enter into Intravenous Iron Drugs  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Intravenous Iron Drugs Sales by Type
    4.2 Global Intravenous Iron Drugs Revenue by Type
    4.3 Intravenous Iron Drugs Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Intravenous Iron Drugs Breakdown Data by Application

6 North America
    6.1 North America Intravenous Iron Drugs by Countries
        6.1.1 North America Intravenous Iron Drugs Sales by Countries
        6.1.2 North America Intravenous Iron Drugs Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Intravenous Iron Drugs by Type
    6.3 North America Intravenous Iron Drugs by Application
    6.4 North America Intravenous Iron Drugs by Company

7 Europe
    7.1 Europe Intravenous Iron Drugs by Countries
        7.1.1 Europe Intravenous Iron Drugs Sales by Countries
        7.1.2 Europe Intravenous Iron Drugs Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Intravenous Iron Drugs by Type
    7.3 Europe Intravenous Iron Drugs by Application
    7.4 Europe Intravenous Iron Drugs by Company

8 Asia Pacific
    8.1 Asia Pacific Intravenous Iron Drugs by Countries
        8.1.1 Asia Pacific Intravenous Iron Drugs Sales by Countries
        8.1.2 Asia Pacific Intravenous Iron Drugs Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Intravenous Iron Drugs by Type
    8.3 Asia Pacific Intravenous Iron Drugs by Application
    8.4 Asia Pacific Intravenous Iron Drugs by Company

9 Central & South America
    9.1 Central & South America Intravenous Iron Drugs by Countries
        9.1.1 Central & South America Intravenous Iron Drugs Sales by Countries
        9.1.2 Central & South America Intravenous Iron Drugs Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Intravenous Iron Drugs by Type
    9.3 Central & South America Intravenous Iron Drugs by Application
    9.4 Central & South America Intravenous Iron Drugs by Company

10 Middle East and Africa
    10.1 Middle East and Africa Intravenous Iron Drugs by Countries
        10.1.1 Middle East and Africa Intravenous Iron Drugs Sales by Countries
        10.1.2 Middle East and Africa Intravenous Iron Drugs Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Intravenous Iron Drugs by Type
    10.3 Middle East and Africa Intravenous Iron Drugs by Application
    10.4 Middle East and Africa Intravenous Iron Drugs by Company

11 Company Profiles
    11.1 Allergan
        11.1.1 Allergan Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.1.4 Intravenous Iron Drugs Product Description
        11.1.5 Recent Development
    11.2 AMAG Pharmaceuticals
        11.2.1 AMAG Pharmaceuticals Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.2.4 Intravenous Iron Drugs Product Description
        11.2.5 Recent Development
    11.3 Daiichi Sankyo
        11.3.1 Daiichi Sankyo Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.3.4 Intravenous Iron Drugs Product Description
        11.3.5 Recent Development
    11.4 Galenica
        11.4.1 Galenica Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.4.4 Intravenous Iron Drugs Product Description
        11.4.5 Recent Development
    11.5 Pharmacosmos
        11.5.1 Pharmacosmos Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.5.4 Intravenous Iron Drugs Product Description
        11.5.5 Recent Development
    11.6 Nippon Shinyaku
        11.6.1 Nippon Shinyaku Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.6.4 Intravenous Iron Drugs Product Description
        11.6.5 Recent Development
    11.7 NOXXON Pharma
        11.7.1 NOXXON Pharma Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.7.4 Intravenous Iron Drugs Product Description
        11.7.5 Recent Development
    11.8 Rockwell Medical
        11.8.1 Rockwell Medical Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.8.4 Intravenous Iron Drugs Product Description
        11.8.5 Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.9.4 Intravenous Iron Drugs Product Description
        11.9.5 Recent Development
    11.10 Wanbang Biopharmaceutical
        11.10.1 Wanbang Biopharmaceutical Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Intravenous Iron Drugs
        11.10.4 Intravenous Iron Drugs Product Description
        11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Intravenous Iron Drugs Raw Material
        13.1.2 Intravenous Iron Drugs Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Intravenous Iron Drugs
    Figure Global Intravenous Iron Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Intravenous Iron Drugs Production Market Share by Types (Product Category) in 2017
    Figure Ferric carboxy maltose Product Picture
    Table Major Manufacturers of Ferric carboxy maltose
    Figure Sucrose Product Picture
    Table Major Manufacturers of Sucrose
    Figure Dextran Product Picture
    Table Major Manufacturers of Dextran
    Table Global Intravenous Iron Drugs Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Nephrology
    Figure Gynecology & Obstetrics
    Figure Gastroenterology
    Figure Oncology
    Figure Cardiology
    Figure Others
    Figure Intravenous Iron Drugs Report Years Considered
    Figure Global Intravenous Iron Drugs Market Size 2016-2025 (Million US$)
    Figure Global Intravenous Iron Drugs Sales 2016-2025 (K Units)
    Table Global Intravenous Iron Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Intravenous Iron Drugs Sales by Regions 2016-2025 (K Units)
    Table Global Intravenous Iron Drugs Sales Market Share by Regions 2016-2025
    Figure Global Intravenous Iron Drugs Sales Market Share by Regions 2016-2025
    Figure 2017 Global Intravenous Iron Drugs Sales Market Share by Regions
    Table Global Intravenous Iron Drugs Revenue by Regions 2016-2025 (Million US$)
    Table Global Intravenous Iron Drugs Revenue Market Share by Regions 2016-2025
    Figure Global Intravenous Iron Drugs Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Intravenous Iron Drugs Revenue Market Share by Regions
    Table Global Intravenous Iron Drugs Sales by Manufacturers (2016-2018) (K Units)
    Table Global Intravenous Iron Drugs Sales Share by Manufacturers (2016-2018)
    Figure Global Intravenous Iron Drugs Sales Share by Manufacturers in 2017
    Table Intravenous Iron Drugs Revenue by Manufacturers (2016-2018) (Million US$)
    Table Intravenous Iron Drugs Revenue Share by Manufacturers (2016-2018)
    Figure Intravenous Iron Drugs Value Share by Manufacturers in 2017
    Table Global Intravenous Iron Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Intravenous Iron Drugs Price (2016-2018) (USD/Unit)
    Table Intravenous Iron Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Intravenous Iron Drugs Product Category
    Table Date of International Manufacturers Enter into Intravenous Iron Drugs Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Intravenous Iron Drugs Sales by Type (2016-2025) (K Units)
    Table Global Intravenous Iron Drugs Sales Share by Type (2016-2025)
    Figure Global Intravenous Iron Drugs Sales Market Share by Type (2016-2025)
    Figure Global Intravenous Iron Drugs Sales Market Share by Type in 2017
    Table Global Intravenous Iron Drugs Revenue by Type (2016-2025) (Million US$)
    Table Global Intravenous Iron Drugs Revenue Share by Type (2016-2025)
    Figure Global Intravenous Iron Drugs Revenue Market Share by Type (2016-2025)
    Figure Global Intravenous Iron Drugs Revenue Market Share by Type in 2017
    Table Intravenous Iron Drugs Price by Type 2013-2018 (USD/Unit)
    Table Global Intravenous Iron Drugs Sales by Application (2016-2025) (K Units)
    Table Global Intravenous Iron Drugs Sales Share by Application (2016-2025)
    Figure Global Sales Intravenous Iron Drugs Market Share by Application (2016-2025)
    Figure Global Sales Intravenous Iron Drugs Market Share by Application (2016-2025)
    Figure North America Intravenous Iron Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure North America Intravenous Iron Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Intravenous Iron Drugs Sales by Countries (2016-2025) (K Units)
    Table North America Intravenous Iron Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Intravenous Iron Drugs Sales Market Share by Countries
    Table North America Intravenous Iron Drugs Revenue by Countries (2016-2025) (Million US$)
    Table North America Intravenous Iron Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Intravenous Iron Drugs Revenue Market Share by Countries
    Figure United States Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure United States Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Intravenous Iron Drugs Sales by Type (2016-2025) (K Units)
    Table North America Intravenous Iron Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 North America Intravenous Iron Drugs Market Share by Type
    Table North America Intravenous Iron Drugs Sales by Application (2016-2025) (K Units)
    Table North America Intravenous Iron Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 North America Intravenous Iron Drugs Market Share by Application
    Table North America Intravenous Iron Drugs Sales by Company (2016-2018) (K Units)
    Table North America Intravenous Iron Drugs Sales Market Share by Company (2016-2018)
    Figure North America Intravenous Iron Drugs Sales Market Share by Company in 2017
    Figure Europe Intravenous Iron Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Intravenous Iron Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Intravenous Iron Drugs Sales by Countries (2016-2025) (K Units)
    Table Europe Intravenous Iron Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Intravenous Iron Drugs Sales Market Share by Countries
    Table Europe Intravenous Iron Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Europe Intravenous Iron Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Intravenous Iron Drugs Revenue Market Share by Countries
    Figure Germany Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (K Units)
    Figure France Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure France Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure UK Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Intravenous Iron Drugs Sales by Type (2016-2025) (K Units)
    Table Europe Intravenous Iron Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Intravenous Iron Drugs Market Share by Type
    Table Europe Intravenous Iron Drugs Sales by Application (2016-2025) (K Units)
    Table Europe Intravenous Iron Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Intravenous Iron Drugs Market Share by Application
    Table Europe Intravenous Iron Drugs Sales by Company (2016-2018) (K Units)
    Table Europe Intravenous Iron Drugs Sales Market Share by Company (2016-2018)
    Figure Europe Intravenous Iron Drugs Sales Market Share by Company in 2017
    Figure Asia Pacific Intravenous Iron Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Intravenous Iron Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Intravenous Iron Drugs Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Intravenous Iron Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Intravenous Iron Drugs Sales Market Share by Countries
    Table Asia Pacific Intravenous Iron Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Intravenous Iron Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Intravenous Iron Drugs Revenue Market Share by Countries
    Figure China Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure China Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure India Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Intravenous Iron Drugs Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Intravenous Iron Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Intravenous Iron Drugs Market Share by Type
    Table Asia Pacific Intravenous Iron Drugs Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Intravenous Iron Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Intravenous Iron Drugs Market Share by Application
    Table Asia Pacific Intravenous Iron Drugs Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Intravenous Iron Drugs Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Intravenous Iron Drugs Sales Market Share by Company in 2017
    Figure Central & South America Intravenous Iron Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Intravenous Iron Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Intravenous Iron Drugs Sales by Countries (2016-2025) (K Units)
    Table Central & South America Intravenous Iron Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Intravenous Iron Drugs Sales Market Share by Countries
    Table Central & South America Intravenous Iron Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Intravenous Iron Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Intravenous Iron Drugs Revenue Market Share by Countries
    Figure Brazil Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Intravenous Iron Drugs Sales by Type (2016-2025) (K Units)
    Table Central & South America Intravenous Iron Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Intravenous Iron Drugs Market Share by Type
    Table Central & South America Intravenous Iron Drugs Sales by Application (2016-2025) (K Units)
    Table Central & South America Intravenous Iron Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Intravenous Iron Drugs Market Share by Application
    Table Central & South America Intravenous Iron Drugs Sales by Company (2016-2018) (K Units)
    Table Central & South America Intravenous Iron Drugs Sales Market Share by Company (2016-2018)
    Figure Central & South America Intravenous Iron Drugs Sales Market Share by Company in 2017
    Figure Middle East and Africa Intravenous Iron Drugs Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Intravenous Iron Drugs Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Intravenous Iron Drugs Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Intravenous Iron Drugs Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Intravenous Iron Drugs Sales Market Share by Countries
    Table Middle East and Africa Intravenous Iron Drugs Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Intravenous Iron Drugs Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Intravenous Iron Drugs Revenue Market Share by Countries
    Figure GCC Countries Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Intravenous Iron Drugs Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Intravenous Iron Drugs Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Intravenous Iron Drugs Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Intravenous Iron Drugs Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Intravenous Iron Drugs Market Share by Type
    Table Middle East and Africa Intravenous Iron Drugs Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Intravenous Iron Drugs Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Intravenous Iron Drugs Market Share by Application
    Table Middle East and Africa Intravenous Iron Drugs Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Intravenous Iron Drugs Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Intravenous Iron Drugs Sales Market Share by Company in 2017
    Table Allergan Company Details
    Table Allergan Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Allergan Recent Development
    Table AMAG Pharmaceuticals Company Details
    Table AMAG Pharmaceuticals Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table AMAG Pharmaceuticals Recent Development
    Table Daiichi Sankyo Company Details
    Table Daiichi Sankyo Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Daiichi Sankyo Recent Development
    Table Galenica Company Details
    Table Galenica Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Galenica Recent Development
    Table Pharmacosmos Company Details
    Table Pharmacosmos Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Pharmacosmos Recent Development
    Table Nippon Shinyaku Company Details
    Table Nippon Shinyaku Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Nippon Shinyaku Recent Development
    Table NOXXON Pharma Company Details
    Table NOXXON Pharma Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table NOXXON Pharma Recent Development
    Table Rockwell Medical Company Details
    Table Rockwell Medical Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Rockwell Medical Recent Development
    Table Sanofi Company Details
    Table Sanofi Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sanofi Recent Development
    Table Wanbang Biopharmaceutical Company Details
    Table Wanbang Biopharmaceutical Intravenous Iron Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Wanbang Biopharmaceutical Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Intravenous Iron Drugs Value Chain
    Table Typical Suppliers of Key Intravenous Iron Drugs Raw Material
    Table Intravenous Iron Drugs Customers List
    Table Intravenous Iron Drugs Sales Channels
    Table Intravenous Iron Drugs Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...